Journal Article Summary
The article investigates the effects of adjusting the target serum level of 25-hydroxy vitamin D during cholecalciferol therapy in critically ill patients suffering from vitamin D deficiency. This topic is significant because vitamin D deficiency is common in critically ill patients and has been linked to increased complications, longer hospital stays, and higher mortality rates. The study aims to determine if a lower target for vitamin D levels can reduce the incidence of hypercalcemia, a condition where calcium levels in the blood become too high, which can lead to serious health issues.
In this study, researchers evaluated 103 critically ill trauma patients, comparing 50 who received cholecalciferol with a target vitamin D level of at least 20 ng/mL to 53 patients from a historical cohort who had a higher target of 30 ng/mL. The results showed a significant reduction in hypercalcemia rates, dropping from 40% in the higher target group to just 4% in the lower target group, with all hypercalcemic patients being asymptomatic. This indicates that lowering the target vitamin D level not only maintained adequate vitamin D levels in most patients but also greatly improved the safety of the treatment.
However, the study has limitations, including its retrospective design and the fact that it was conducted at a single center with a small patient population. Additionally, the definition of vitamin D deficiency used may vary from other guidelines, and the study did not measure certain factors that could provide more insight into the causes of hypercalcemia. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding the management of vitamin D levels and the potential risks associated with vitamin D therapy in critically ill patients.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Dickerson Roland N., Turner Stephen C., Holmes Whitney L., Van Matre Edward T., Swanson Joseph M., Byerly Saskya, Filiberto Dina M., Fischer Peter E.. Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients. Nutrients 2022. DOI: 10.3390/nu14081650. PMID: 35458212. PMCID: PMC9032836.
Featured Pill Pals Product
Ergocalciferol 1,250 mcg Capsules --- 4 Count / Taken Once A Week --- Generic for Drisdol --- Bion Pharma
Ergocalciferol 1,250 mcg Capsules — 4 Count / Taken Once A Week — Generic for Drisdol — Bion Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
